Prior to this role, Mr. Mullikin worked for Novartis, focusing on financial and strategic planning as well as health economics and pricing. Before Novartis, he was a healthcare equity analyst at Adage Capital Management and Piper Sandler and began his career in the finance and strategy practice at Deloitte Consulting.
Mr. Mullikin earned his M.B.A. in finance from the MIT Sloan School of Management and his B.A. in economics from the University of Chicago.